tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Emergent BioSolutions Inc

EBS
Add to Watchlist
6.800USD
-0.220-3.13%
Close 09-18 16:00（ET）
347.81MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)6.800USD-0.030-0.44%

Emergent BioSolutions Inc

6.800
-0.220-3.13%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

EBS Financials

See Emergent BioSolutions Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
347.81M
Dividend TTM
0.00
P/E TTM
-49.93
EPS TTM
-0.14
Revenue
742.90M
Net Profit
-190.60M
ROE
-1.60%
ROA
-0.63%

Emergent BioSolutions Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-3.49/0.11
Revenue / Forecast
234.30M/177.50M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-1477.35%-3.49
-89.52%0.13
-80.78%-1.04
-55.48%0.96
95.89%-0.22
625.02%1.25
39.22%-0.58
142.52%2.16
-4.43%-5.38
104.65%0.17
37.58%-0.95
---5.08
---5.15
---3.71
---1.52
----
----
----
----
----
Revenue
66.29%234.30M
-29.75%156.10M
-23.63%148.70M
-21.34%231.10M
-44.68%140.90M
-26.03%222.20M
-29.61%194.70M
8.61%293.80M
-24.62%254.70M
82.84%300.40M
-15.49%276.60M
12.76%270.50M
39.23%337.90M
-46.57%164.30M
-53.52%327.30M
-27.08%239.90M
-38.94%242.70M
-10.35%307.50M
20.77%704.10M
-14.59%329.00M
Net Profit
-1401.67%-180.20M
-90.00%6.80M
-74.44%-54.60M
-55.40%51.20M
95.76%-12.00M
655.56%68.00M
36.77%-31.30M
143.58%114.80M
-8.34%-283.10M
104.83%9.00M
34.70%-49.50M
-202.41%-263.40M
-363.30%-261.30M
-4932.43%-186.20M
-142.61%-75.80M
-166.36%-87.10M
-1326.09%-56.40M
-105.31%-3.70M
-4.05%177.90M
-182.78%-32.70M
Net Margin
-803.05%-76.91%
-85.77%4.36%
-128.40%-36.72%
-43.30%22.15%
92.34%-8.52%
921.46%30.60%
10.17%-16.08%
140.13%39.07%
-43.73%-111.15%
102.64%3.00%
22.73%-17.90%
---97.38%
---77.33%
---113.33%
---23.16%
----
----
----
----
----
Gross Margin
11.05%58.56%
-11.06%53.88%
8.91%42.91%
7.68%62.74%
424.42%52.73%
16.80%60.58%
19.09%39.39%
68.22%58.27%
-137.29%-16.25%
647.48%51.86%
-0.21%33.08%
--34.64%
--43.59%
--6.94%
--33.15%
----
----
----
----
----
Debt to assets ratio
10.55%52.10%
-6.94%43.44%
-9.15%43.39%
1.23%45.39%
-17.28%47.12%
-7.06%46.68%
1.22%47.76%
-1.51%44.84%
37.42%56.97%
5.95%50.23%
6.27%47.18%
--45.52%
--41.45%
--47.41%
--44.40%
----
----
----
----
----
Income Statement
Revenue
66.29%234.30M
-29.75%156.10M
-23.63%148.70M
-21.34%231.10M
-44.68%140.90M
-26.03%222.20M
-29.61%194.70M
8.61%293.80M
-24.62%254.70M
82.84%300.40M
-15.49%276.60M
12.76%270.50M
39.23%337.90M
-46.57%164.30M
-53.52%327.30M
-27.08%239.90M
-38.94%242.70M
-10.35%307.50M
20.77%704.10M
-14.59%329.00M
Operating profit
2351.85%66.20M
-79.49%10.50M
-37.37%-13.60M
-7.20%65.70M
101.70%2.70M
30.28%51.20M
77.70%-9.90M
2066.67%70.80M
-1262.04%-159.20M
128.50%39.30M
20.29%-44.40M
92.05%-3.60M
119.03%13.70M
-2254.69%-137.90M
-118.09%-55.70M
-30.55%-45.30M
-596.55%-72.00M
-93.29%6.40M
17.70%307.90M
-133.33%-34.70M
Net Profit
-1401.67%-180.20M
-90.00%6.80M
-74.44%-54.60M
-55.40%51.20M
95.76%-12.00M
655.56%68.00M
36.77%-31.30M
143.58%114.80M
-8.34%-283.10M
104.83%9.00M
34.70%-49.50M
-202.41%-263.40M
-363.30%-261.30M
-4932.43%-186.20M
-142.61%-75.80M
-166.36%-87.10M
-1326.09%-56.40M
-105.31%-3.70M
-4.05%177.90M
-182.78%-32.70M
Balance Sheet
Current assets
-7.44%666.00M
-9.79%637.60M
10.66%662.50M
18.97%786.90M
9.93%719.50M
3.58%706.80M
-11.89%598.70M
-8.24%661.40M
-15.84%654.50M
-44.13%682.40M
-43.86%679.50M
-35.56%720.80M
-28.27%777.70M
11.00%1.22B
-4.85%1.21B
0.63%1.12B
-6.70%1.08B
-6.84%1.10B
6.37%1.27B
15.93%1.11B
Total current liabilities
-3.38%122.80M
32.89%148.70M
-18.60%132.20M
-40.63%136.50M
-79.49%127.10M
-82.24%111.90M
-75.07%162.40M
-65.38%229.90M
-10.60%619.70M
-48.16%630.20M
-47.00%651.30M
147.39%664.00M
150.52%693.20M
387.84%1.22B
228.76%1.23B
-26.55%268.40M
-26.76%276.70M
-32.69%249.20M
-2.78%373.80M
22.08%365.40M
Total assets
-21.19%1.12B
-7.41%1.32B
-5.12%1.32B
-1.14%1.46B
-6.37%1.42B
-20.93%1.43B
-23.78%1.39B
-21.94%1.48B
-30.54%1.51B
-38.86%1.80B
-42.42%1.82B
-34.91%1.89B
-20.35%2.18B
6.09%2.95B
7.01%3.17B
1.43%2.91B
-6.17%2.74B
-4.13%2.78B
2.63%2.96B
9.60%2.87B
Total liabilities
-11.98%775.40M
-8.71%797.30M
-12.23%796.00M
-9.38%878.50M
-21.85%880.90M
-23.37%873.40M
-22.74%906.90M
-18.94%969.40M
-7.80%1.13B
-34.77%1.14B
-34.00%1.17B
-18.04%1.20B
0.02%1.22B
44.98%1.75B
32.73%1.78B
8.51%1.46B
-10.89%1.22B
-12.50%1.21B
-6.70%1.34B
-1.47%1.34B
Total equity
-36.33%341.40M
-5.36%523.10M
8.24%522.60M
14.58%582.50M
38.80%536.20M
-16.75%552.70M
-25.64%482.80M
-27.08%508.40M
-59.60%386.30M
-44.79%663.90M
-53.21%649.30M
-51.89%697.20M
-36.80%956.30M
-23.66%1.20B
-14.29%1.39B
-4.82%1.45B
-1.98%1.51B
3.45%1.58B
11.89%1.62B
21.67%1.52B
Cash Flow Statement
Net operating income
-47.27%56.10M
-201.79%-33.80M
197.25%77.70M
-101.50%-2.30M
124.00%106.40M
82.11%-11.20M
-348.91%-79.90M
156.17%153.70M
141.52%47.50M
65.98%-62.60M
-65.41%32.10M
181.08%60.00M
-633.33%-114.40M
-393.30%-184.00M
-71.79%92.80M
-543.11%-74.00M
47.47%-15.60M
-831.37%-37.30M
34.23%329.00M
-84.13%16.70M
Net investment
-404.07%-52.30M
-104.03%-2.40M
-113.64%-3.90M
-103.04%-3.40M
473.91%17.20M
650.93%59.50M
350.88%28.60M
692.59%112.00M
-101.79%-4.60M
28.48%-10.80M
74.89%-11.40M
93.04%-18.90M
902.80%257.70M
53.11%-15.10M
2.78%-45.40M
-392.03%-271.60M
52.09%-32.10M
42.60%-32.20M
-29.72%-46.70M
-20.79%-55.20M
Net financing
-281.25%-24.40M
-2750.00%-11.40M
-22880.00%-113.90M
91.18%-15.90M
87.43%-6.40M
-100.98%-400.00K
-89.36%500.00K
-319.30%-180.30M
89.55%-50.90M
487.62%40.70M
-98.67%4.70M
-118.75%-43.00M
-1485.99%-486.90M
85.11%-10.50M
421.00%353.10M
4686.00%229.30M
-707.89%-30.70M
-217.57%-70.50M
-4682.61%-110.00M
-105.74%-5.00M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its total revenue reached 742.90M, with a year-on-year change of 1.04B.

What are the current assets of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its current assets were 662.50M, with a year-on-year change of 10.66.

What are the total assets of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its total assets of Emergent BioSolutions Inc were 1.32B, with a year-on-year change of -5.12.

What are the total liabilities of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its total liabilities of Emergent BioSolutions Inc were 796.00M, with a year-on-year change of -12.23.

What is the total equity of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its total equity of Emergent BioSolutions Inc was 522.60M, with a year-on-year change of 8.24.

What is the net operating income of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its net operating income of Emergent BioSolutions Inc was 114.40M, with a year-on-year change of 293.90.

What is the net investment of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its net investment of Emergent BioSolutions Inc was 69.40M, with a year-on-year change of -44.57.

What is the net financing of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its net financing of Emergent BioSolutions Inc was -136.60M, with a year-on-year change of 28.11.

What is the Earnings Per Share (EPS) of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.98, with a year-on-year change of 127.34.

What is the net income of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its net income was 52.60M, with a year-on-year change of 127.60.

What is the net margin of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its net profit margin was 7.08, with a year-on-year change of 138.77.

What is the gross margin of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its gross margin was 56.09, with a year-on-year change of 61.57.

What is the debt-to-asset ratio of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its debt-to-asset ratio was 43.39, with a year-on-year change of -9.15.

What is the Return on Equity (ROE) of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its Return on Equity (ROE) was 10.46, with a year-on-year change of 131.07.

What is the Return on Assets (ROA) of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its Return on Assets (ROA) was 3.88, with a year-on-year change of 132.74.

What is the operating profit of Emergent BioSolutions Inc?

According to Emergent BioSolutions Inc's FY2025 earnings report, its operating profit was 114.40M, with a year-on-year change of 293.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy